Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Although malaria is one of the differential diagnoses among travelers to endemic area, delayed hemolysis following malaria treatment with artemisinin-derivative drugs during travel should be aware. We highlight the clinical perspective for clinicians to consider this clinical phenomenon to detect any delayed hemolytic event early and prevent potentially serious consequences.

Original publication

DOI

10.1093/jtm/taab171

Type

Journal article

Journal

J Travel Med

Publication Date

21/10/2021

Keywords

Antimalarial drugs, Artesunate, Delayed hemolysis, Malaria, Returning travelers, Treatment